How Are Liquid Biopsies Changing Cancer Diagnosis and Monitoring?
Liquid biopsies involve analyzing circulating tumor DNA (ctDNA) or circulating tumor cells (CTCs) from a blood sample. This non-invasive method allows for early detection, monitoring treatment response, and identifying mutations that may guide therapeutic decisions. Liquid biopsies are poised to complement or, in some cases, replace traditional tissue biopsies.
